Biocon Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Biocon Ltd.

Biocon Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.

2014

2015

2016

2017

2018

Net Income before Extraordinaries

5,377

6,241

6,091

6,881

4,531

Depreciation, Depletion & Amortization

2,036

2,210

2,487

2,772

3,851

Other Funds

Funds from Operations

5,371

5,969

5,762

9,479

7,651

Changes in Working Capital

377

3,540

1,762

2,270

1,065

Net Operating Cash Flow

5,748

2,429

4,000

7,209

6,586

Capital Expenditures

7,985

9,169

8,037

7,621

9,165

Sale of Fixed Assets & Businesses

3,677

Purchase/Sale of Investments

2,073

2,079

4,184

1,239

1,689

Net Investing Cash Flow

9,789

5,414

12,212

6,380

7,442

Cash Dividends Paid - Total

1,500

1,446

2,201

787

Issuance/Reduction of Debt, Net

6,027

3,273

13,429

1,232

619

Net Financing Cash Flow

4,527

1,867

11,177

1,189

1,238

Net Change in Cash

830

1,053

3,000

473

2,090

Free Cash Flow

2,137

5,952

2,180

1,125

796

Net Assets from Acquisitions

2,154

Other Sources

241

153

Change in Capital Stock

168

Exchange Rate Effect

344

113

About Biocon

View Profile

Address	20th KM, Hosur Road Bangalore Karnataka 560100 India
Employees	-
Website	http://www.biocon.com
Updated	09/14/2018
Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc.